Keywords: Lundbeck, Biotie Therapeis, Selincro, Licensing deal, Equity stake, Share issue, Alcohol dependence

Lundbeck takes 5% stake in Biotie; amends Selincro licensing deal

Article | 07 September 2012

Print This

Danish CNS drug specialist Lundbeck A/S (LUND: DC) said this morning that it has made an investment of 10 million ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in